Every 8-K that SIRIUSPOINT LTD WT 26 (SSPFF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow SSPFF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SSPFF filings page.
SiriusPoint Ltd. reported results of its 2026 annual general meeting of shareholders held on May 20, 2026. Shareholders elected two Class I directors, Susan L. Cross and Sabra R. Purtill, each to serve until the 2029 annual meeting, with strong support in the “for” votes.
Shareholders also approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers as disclosed in the proxy statement. They further approved the appointment of PricewaterhouseCoopers LLP as independent auditor through the 2027 annual meeting and authorized the board’s Audit Committee to set the auditor’s remuneration.
In addition, shareholders approved the SiriusPoint SharePlan, which had been adopted by the board on February 12, 2026, subject to shareholder approval. The company noted that certain voting limitations in its Bye-laws were not applied in tabulating votes for this meeting.
SiriusPoint Ltd. is reorganizing its operations into four business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and a London Market Specialty division that includes Lloyd’s. The company is combining its North America and International Programs into a single Global P&C Programs division led by Patrick Charles.
The new London Market Specialty division, highlighting the importance of SiriusPoint’s London platform and Syndicate 1945, will be led by David Govrin, who also serves as CEO Global Reinsurance. As part of these changes, Rob Gibbs, President & CEO of SiriusPoint International, will leave the company under a mutual separation agreement based on the Executive Severance Plan. The company furnished a press release as Exhibit 99.1 describing these structural changes and the leadership transition.
SiriusPoint Ltd. reported very strong fourth-quarter and full-year 2025 results, highlighting profitable growth and capital returns. Net income available to common shareholders reached $240 million in Q4, or $1.97 per diluted share, with operating earnings per share of $0.70. Annual net income was $444 million, or $3.64 per diluted share, and operating earnings per share rose 49% to $2.55. The company delivered an annualized return on equity of 44.9% in Q4 and 22.1% for the year, with operating ROE of 16.2%. Gross written premiums grew 16% in 2025 and the Core combined ratio was 91.7%, indicating solid underwriting profitability.
Book value per common share increased to $19.40, while book value per diluted share excluding AOCI rose 23.6% to $18.10. SiriusPoint announced it will redeem all Series B preference shares, expecting its leverage ratio to fall to about 23%, and plans to repurchase $100 million of common shares over the next 12 months. The balance sheet remained strong with a year-end BSCR estimate of 247%. Strategic actions included selling a 49% stake in Arcadian for $140.4 million (with an expected pre-tax gain of about $25 million in the first quarter of 2026) and agreements to acquire Assist America for approximately $42.5 million and the World Nomads travel insurance business to expand medical and travel assistance capabilities.
SiriusPoint Ltd. announced that its wholly owned subsidiary International Medical Group (IMG) has signed a definitive agreement to acquire the World Nomads travel insurance business from nib Group. World Nomads generates approximately $40 million of gross written premium and is a global travel insurance and lifestyle brand.
The deal is expected to significantly expand IMG’s travel insurance distribution, adding a broad base of independent, lifestyle, and adventure travelers and extending its reach to Australia, Brazil, and Canada. Together with IMG’s recent acquisition of Assist America, which produces around $20 million in annual assistance revenues, the combination creates an integrated travel insurance and assistance platform.
The company states that both the World Nomads and Assist America acquisitions are accretive to return on equity and earnings per share. An initial closing for the majority of World Nomads is targeted for the second or third quarter of 2026, with final closing in the second half of 2027, in each case subject to regulatory approvals and other customary conditions.
SiriusPoint Ltd. reports that a subsidiary has completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited to Comet Bidco Limited, an acquisition vehicle of funds affiliated with Lee Equity Partners. Under the Share Purchase Agreement dated October 3, 2025, SiriusPoint Bermuda Insurance Company Ltd., as seller, received cash consideration of $140 million, subject to customary post-closing adjustments. The transaction closed after all customary closing conditions were met, including required regulatory approvals.
SiriusPoint Ltd. has announced the full redemption of all 8,000,000 of its 8.00% Resettable Fixed Rate Preferred Shares, Series B. The redemption will occur on February 26, 2026, retiring this entire preferred share series.
The company also stated its intent to delist and deregister the Series B Preference Shares from the New York Stock Exchange and under U.S. securities laws. These steps consolidate its capital structure by removing this listed preferred security from public trading.
SiriusPoint Ltd. completed the previously announced sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of its supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc.
The Seller received $250 million in cash consideration, subject to deductions including transaction expenses. The transaction closed after satisfaction of customary closing conditions.
SiriusPoint Ltd. (SPNT) filed an 8-K stating it furnished its third-quarter 2025 results press release (Exhibit 99.1), a financial supplement (Exhibit 99.2), and an investor slide presentation (Exhibit 99.3). These materials were provided under Items 2.02 and 7.01 and are not deemed filed under the Exchange Act.
Under Item 8.01, the Audit Committee approved a quarterly cash dividend of $0.50 per share on the company’s 8.00% Resettable Fixed Rate Preference Shares, Series B, payable on November 28, 2025 to shareholders of record on November 13, 2025 (press release in Exhibit 99.4).